HELENA, Mont. — In 2023, a group of 16 young Montanans won a much-heralded climate change case that said the state had deprived them of a “clean and healthful environment,” a right enshrined in Montana’s constitution. Their victory in Held v. Montana, later upheld by the state Supreme Court, resounded across the country, showing that…
Government documents viewed by KFF Health News show a drop in patients receiving care this year at the National Institutes of Health’s renowned research hospital, a 200-bed facility at NIH headquarters in Maryland. We previously reported a decrease in the number of patients being treated at the NIH Clinical Center from February through April. Since then,…
By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful Bill was a significant milestone in virtual care. Though it specifically addresses pre-deductible telehealth services in high-deductible health plans, the legislation has far wider implications for both care delivery and insurance design, especially in the commercial insurance market. In fact…
In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workflows are streamlined and value is delivered across stakeholders. This will differentiate winning AI startups from incumbents and copycat competitors, said Morgan Cheatham, head of healthcare and life sciences at Breyer Capital. The post…
Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs. The post A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds appeared first on MedCity News.
A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from its 2019 acquisition of Taris Biomedical. The post FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option appeared…
The Inflation Reduction Act (IRA) created the Medicare Drug Price Negotiation Program (DPNP). The aim of the program is to reduce the cost of pharmaceuticals for Medicare. A key question is how are investors viewing this policy and how is it impacting their investment decisions. A paper by Canestaro, Patterson and Campbell (2025) aimed to…
Executives of the California Medicaid insurer discuss the impact of new CalAIM benefits on the deployment of community health workers
Now is a good time for health systems to step back and ask some foundational questions instead of rushing into their next AI purchase. The post The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results appeared first on MedCity News.
Data is not optional; it is essential to financial stability and strategic growth. The organizations that thrive will be those that use data to lead, not follow. The post Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare appeared first on MedCity News.